We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
-4.09%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.52B
AUM Growth
-$173M
(-6.4%)
Cap. Flow
-$49.2M
Cap. Flow
% of AUM
-1.95%
Top 10 Holdings %
Top 10 Hldgs %
37.25%
Holding
3,473
New
218
Increased
908
Reduced
1,467
Closed
292
Avg Time Held Equity + Options
3
years
Top 10 Avg Time Held Equity + Options
2.4
years
Top 20 Avg Time Held Equity + Options
2.4
years
Avg Time Held Equity only
3
years
Top 10 Avg Time Held Equity only
2.4
years
Top 20 Avg Time Held Equity only
2.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Fallen Angels USD Bond ETF
FALN
|
+$9.31M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$6.87M |
| 3 |
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
|
+$3.6M |
| 4 |
Corcept Therapeutics
CORT
|
+$3M |
| 5 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$2.68M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard ESG US Stock ETF
ESGV
|
+$9.63M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$7.01M |
| 3 |
Microsoft
MSFT
|
+$5.41M |
| 4 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$5.16M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$4.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.1% |
| 2 | Technology | 15.39% |
| 3 | Financials | 8.2% |
| 4 | Healthcare | 7.16% |
| 5 | Consumer Discretionary | 5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2851
Tompkins Financial
TMP
$1.4B
| $1K | ﹤0.01% |
17
-148
| -90% | -$11.9K |
2021 Q3
2 quarters
|
|
2852
TriNet
TNET
$3.23B
| $1K | ﹤0.01% |
+13
| New | +$1.15K |
2022 Q1
0 quarters
|
|
2853
State Street DoubleLine Total Return Tactical ETF
TOTL
$3.67B
| $1K | ﹤0.01% |
16
| – | – |
2021 Q4
1 quarter
|
|
2854
TPG
TPG
$7.23B
| $1K | ﹤0.01% |
+18
| New | +$557 |
2022 Q1
0 quarters
|
|
2855
TPG RE Finance Trust
TRTX
$454M
| $1K | ﹤0.01% |
56
+25
| +81% | +$304 |
2021 Q4
1 quarter
|
|
2856
TTM Technologies
TTMI
$10.7B
| $1K | ﹤0.01% |
83
-242
| -74% | -$3.32K |
2020 Q4
5 quarters
|
|
2857
Twist Bioscience
TWST
$9.58B
| $1K | ﹤0.01% |
25
+21
| +525% | +$1.16K |
2021 Q2
3 quarters
|
|
2858
Ultra Clean Holdings
UCTT
$2.53B
| $1K | ﹤0.01% |
14
| – | – |
2021 Q3
2 quarters
|
|
2859
Universal Health Realty Income Trust
UHT
$531M
| $1K | ﹤0.01% |
+10
| New | +$580 |
2022 Q1
0 quarters
|
|
2860
Unitil
UTL
$973M
| $1K | ﹤0.01% |
22
-72
| -77% | -$3.52K |
2016 Q4
21 quarters
|
|
2861
Vericel Corp
VCEL
$2.1B
| $1K | ﹤0.01% |
+29
| New | +$1.05K |
2022 Q1
0 quarters
|
|
2862
Vanguard S&P Small-Cap 600 Value ETF
VIOV
$1.76B
| $1K | ﹤0.01% |
+8
| New | +$705 |
2022 Q1
0 quarters
|
|
2863
Janus Henderson Short Duration Income ETF
VNLA
$3.56B
| $1K | ﹤0.01% |
+15
| New | +$739 |
2022 Q1
0 quarters
|
|
|
VRE
2864
DELISTED
Veris Residential
VRE
| $1K | ﹤0.01% |
68
-93
| -58% | -$1.61K |
2020 Q3
6 quarters
|
|
2865
Bristow Group
VTOL
$1.12B
| $1K | ﹤0.01% |
22
| – | – |
2021 Q4
1 quarter
|
|
2866
vTv Therapeutics
VTVT
$109M
| $1K | ﹤0.01% |
38
| – | – |
2020 Q2
7 quarters
|
|
2867
Washington Trust Bancorp
WASH
$707M
| $1K | ﹤0.01% |
10
-463
| -98% | -$25.9K |
2021 Q2
3 quarters
|
|
2868
Xencor
XNCR
$1.78B
| $1K | ﹤0.01% |
34
-83
| -71% | -$2.68K |
2021 Q2
3 quarters
|
|
2869
XP
XP
$15.2B
| $1K | ﹤0.01% |
32
-20
| -38% | -$624 |
2020 Q3
6 quarters
|
|
2870
DELISTED
ZimVie
ZIMV
| $1K | ﹤0.01% |
+62
| New | +$1.46K |
2022 Q1
0 quarters
|
|
2871
Zurn Elkay Water Solutions
ZWS
$7.77B
| $1K | ﹤0.01% |
37
-241
| -87% | -$8.01K |
2021 Q2
3 quarters
|
|
2872
Nebius Group N.V.
NBIS
$51.2B
| $1K | ﹤0.01% |
60
+21
| +54% | +$997 |
2016 Q4
21 quarters
|
|
2873
Oruka Therapeutics
ORKA
$4.89B
| $1K | ﹤0.01% |
20
| – | – |
2021 Q3
2 quarters
|
|
2874
Pursuit Attractions and Hospitality Inc
PRSU
$1.5B
| $1K | ﹤0.01% |
25
-10
| -29% | -$366 |
2016 Q4
21 quarters
|
|
2875
JBT Marel
JBTM
$5.5B
| $1K | ﹤0.01% |
5
-1
| -17% | -$128 |
2021 Q1
4 quarters
|
|
Similar funds
Parallel Advisors's Q1 2022 Portfolio in Review
As of Q1 2022, Parallel Advisors held 3,473 positions worth $2.52B, down 6.4% from $2.69B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Parallel Advisors's Q1 2022 filing shows 218 new, 908 increased, 1,467 reduced and 292 closed positions. Its largest new stake was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M. The largest sale was Vanguard ESG US Stock ETF, an estimated $9.63M.
By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, down from 51% a quarter earlier, followed by Technology and Financials.
- Parallel Advisors's largest Q1 2022 buy was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M.
- Parallel Advisors added most to iShares Fallen Angels USD Bond ETF in Q1 2022, an estimated $9.31M increase.
- Parallel Advisors's biggest Q1 2022 reduction was Vanguard ESG US Stock ETF, cutting an estimated $9.63M.
- Parallel Advisors fully exited State Street SPDR Nuveen ICE Short Term Municipal Bond ETF in Q1 2022, selling an estimated $1.09M.
- Parallel Advisors's ten largest holdings make up 37% of its $2.52B portfolio in Q1 2022.
- Parallel Advisors opened 218 new positions and closed 292 in Q1 2022.
- Parallel Advisors's portfolio value fell 6.4% quarter-over-quarter to $2.52B.
Based on Parallel Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.